Cefepime in febrile patients with chemotherapy induced neutropenia.

被引：0
|
作者：
Varthalitis, I [1 ]
Athanassiou, A [1 ]
Papadopoulou, M [1 ]
Vlachopoulos, V [1 ]
Christakis, G [1 ]
Pectassides, D [1 ]
机构：
[1] Metaxa Canc Hosp, Dept Med Oncol A, Piraeus, Greece
来源：
ANNALS OF ONCOLOGY | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
688P
引用
收藏
页码：150 / 150
页数：1
相关论文
共 50 条
  • [1] Cefepime monotherapy as initial treatment for patients with febrile neutropenia.
    Montalar, J
    Segura, A
    Bosch, C
    Galán, A
    Juan, O
    Yuste, A
    Molins, C
    [J]. ANNALS OF ONCOLOGY, 2000, 11 : 151 - 151
  • [2] Derivation of a prognostic model for chemotherapy-induced febrile neutropenia.
    Ahn, Shin
    Lee, Yoon-Seon
    Lee, Jae-Lyun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [3] Cost of chemotherapy-related febrile neutropenia.
    Weycker, D.
    Malin, J.
    Glass, A.
    Oster, G.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 317S - 317S
  • [4] Piperacillin-tazobactam versus cefepime monotherapy for pediatric febrile neutropenia.
    Kebudi, R
    Ayan, I
    Görgün, Ö
    Gürler, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 812S - 812S
  • [5] Cefepime as single agent in continuous intravenous infusion for initial treatment in febrile neutropenia.
    Agape, P
    Pariente, L
    Breilh, D
    Texier-Maugein, J
    Lounici, A
    Pigneux, A
    Boiron, JM
    Lerner, D
    Marit, G
    Reiffers, J
    [J]. BLOOD, 1998, 92 (10) : 52B - 52B
  • [6] The economics of febrile neutropenia.
    Lyman, GH
    Kuderer, NM
    Green, J
    [J]. BLOOD, 1996, 88 (10) : 1374 - 1374
  • [7] Cefepime monotherapy in paediatric patients with febrile neutropenia
    Patel, Kirti
    Shah, Sandip
    Patel, Apurva
    Shah, Pankaj
    Parikh, Bharat
    Anand, Asha
    Talati, Shailesh
    Panchal, Harsha
    Parikh, Sonia
    Gupta, Ashish
    Srivastav, Ratnesh
    Kattimani, Kiran
    Mittal, Suman
    Kukroo, Abhishek
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 49 (04) : 483 - 483
  • [8] Randomized comparison of ceftriaxone-amikacin versus cefepime as empirical therapy for patients with acute leukemia and febrile neutropenia.
    Borbolla, JR
    Lopez-Hernandez, MA
    DeDiego, J
    Alvarado, ML
    Gonzalez-Avante, M
    Trueba, E
    Jimenez, R
    [J]. BLOOD, 1999, 94 (10) : 218B - 218B
  • [9] Febrile neutropenia. Antifungal therapy
    Petrikkos, G
    [J]. BALKAN CONGRESS OF ONCOLOGY, 1996, : 719 - 726
  • [10] Risk factors for readmission in patients admitted for febrile neutropenia.
    Van Klein, Justin
    Gillis-Smith, Andrew J.
    Slotkin, Rebecca
    Reagan, John Leonard
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345